Kappa Bioscience
Cardio Double Strength

Your browser does not support SVG

Food Supplement with EPA, DHA, Vitamin K2 and Vitamin D3


  • Label Claim
  • Health Claim
  • Structure Function Claims
  • Associated effects
  • Ingredients
  • Chapter
per Portion% NRV
Eicosapenthaenoic acid (TG)360 mg
Docosahexaenoic acid (TG)270 mg
Vitamin K2 MK-775 μg100
Vitamin D35 μg100
Health applicationTarget groupDaily portionShelf life
Cardio Health Adults 1 Vegicaps® Capsule6 months 

EPA and DHA contribute to the normal function of the heart.

Vitamin K contributes to the maintenance of normal bones.

Vitamin D contributes to normal absorption/utilisation of calcium and to normal blood calcium levels.

Vitamin K2 (MK-7) helps maintain a healthy heart.
Vitamin K2 (MK-7) has an important function in bone development.

Vitamin K2 activates matrix GLA proteins (MGP) which bind excess calcium in blood to prevent deposit in vessels and arteries.

Vitamin K2 reduces the calcification of arterial plaques and puts calcium in balance.

Fish oil rich in EPA and DHA - Modified starch (hydroxypropyl starch from maize), Firming agent (glycerol), Gelling agent (Carrageenan), Menaquinone-7 (K2VITAL®), Colouring agents (Titanium dioxides, Iron oxides), Acidity regulator (disodium phosphate), Cholecalciferol

Heart Health

More information



 

Dosage Form and Benefits

Cardio K2VITAL® Double Strength Vegicaps® Capsules deliver the cardiovascular benefits of EPA and DHA alongside the calcium-mediating benefits of vitamin K2 and D3. The EPA and DHA from fish oils in Cardio K2VITAL®Double Strength Vegicaps® Capsules contribute to the normal function of the heart. This product serves a large and growing consumer market in the omega-3/fish-oils categories. What makes this product stand-out is the inclusion of K2VITAL® premium vitamin K2 and vitamin D3. Both contribute to the proper utilization of calcium in the body, en- suring that calcium is delivered to bones and away from the heart. Cardiovascular calcification is the underlying reason for most heart attacks and strokes, and vitamin K2 prevents and reverses this type of calcification. Vegicaps® capsules are an ideal solution for consumers seeking an alternative to gelatin capsules. Patented Vegicaps® capsules are plant-based capsules free from gluten and sugar.

 

 

 


Product Concept

The Cardio K2VITAL® Double Strength Vegicaps® Capsules formulation delivers a 360 mg dose of EPA and 270 mg dose of DHA which support proper cardio- vascular health and the normal function of the heart. The omega-3 and fish oils markets are large and growing, and it is becoming more and more common for consumers to supplement their daily multivitamin product with an additional EPA/DHA product. The downside of category growth is a crowded market full of similar products that lack differentiation and commercial advantage. Cardio K2VITAL® Double Strength Vegicaps® Capsules ‘rise above the crowd’ with the premium positioning provided by K2VITAL® vitamin K2 and D3. Both mediate cal- cium in the body. Vitamin K2 by activating matrix Gla proteins (MGP) which help protect the heart against unhealthy calcification. Vitamin D3 has also been shown to have restorative effect on the cardiovascular system.


Download LookBook 2019

The K2 Formulations LookBook, now in its fifth edition, defines over 120 ready-to-launch bone health, heart health and multivitamin K2 product concepts. The LookBook is designed to shorten the product development cycle, from months to weeks or days.

Download LookBook

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Friesenweg 4 | Building 13 | 22763 Hamburg
Germany

Headquarter
Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo
Norway

+49 40 6094087 0